Company / Net Income
ENDONOVO THERAPEUTICS, INC. Net Income History
FY2011-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$18.5M
FY2022
5-year range
-$18.5M / -$395.6K
FY2018-FY2022
Trend
-495.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed -495% YoY in FY2022, a notable deviation from the 8-year average annual change of -347%.
Based on SEC 10-K filings.
-$18M in FY2022.
Declined from -$395,584 to -$18M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, net income decreased 495.0% year-over-year.
- Peak net income was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$18.5M | -495.0% |
| FY2021 | -$3.1M | -684.9% |
| FY2020 | -$395.6K | +97.7% |
| FY2019 | -$17.3M | -169.0% |
| FY2018 | -$6.4M | -21.1% |
| FY2016 | -$5.3M | +21.4% |
| FY2015 | -$6.8M | -605.1% |
| FY2014 | -$959.5K | -919.8% |
| FY2011 | -$94.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026